Prostate Cancer Therapeutics Market to 2022 - Global Strategic Business Report - Rising Incidences Drives the Market - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Prostate Cancer Therapeutics - Global Strategic Business Report" report to their offering.

The report provides separate comprehensive analytics for the US, Canada, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.

This report analyzes the worldwide markets for Prostate Cancer Therapeutics in US$ Million by the following Segments: Hormone Therapy, and Other Therapies.

The report profiles 76 companies including many key and niche players such as

  • AbbVie, Inc. (US)
  • Æterna Zentaris Inc. (Canada)
  • Allergan plc (Ireland)
  • Amgen Inc. (US)
  • Astellas Pharma Inc. (Japan)
  • AstraZeneca Plc. (UK)
  • Bavarian Nordic (Denmark)
  • Bayer Healthcare AG (Germany)
  • Bristol-Myers Squibb Company (US)
  • Debiopharm Group (Switzerland)
  • Endo Pharmaceuticals Inc. (US)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Genentech Inc. (US)
  • GlaxoSmithKline Plc. (UK)
  • Janssen Biotech, Inc. (US)
  • Novartis AG (Switzerland)
  • Pfizer Inc. (US)
  • Progenics Pharmaceuticals, Inc. (US)
  • Sanofi S.A. (France)
  • Spectrum Pharmaceuticals, Inc. (US)
  • Takeda Pharmaceutical Company Limited (Japan)
  • TOLMAR Pharmaceuticals, Inc. (US)
  • Valeant Pharmaceuticals International, Inc. (Canada)

Key Topics Covered:

1. Industry Overview

2. Product Overview

3. Drug Approvals And Clinical Studies

4. Product Launches

5. Recent Industry Activity

6. Focus On Select Global Players

7. Global Market Perspective

Total Companies Profiled: 76 (including Divisions/Subsidiaries 84)

  • The United States (47)
  • Canada (6)
  • Japan (4)
  • Europe (23)
  • - France (5)
  • - Germany (3)
  • - The United Kingdom (5)
  • - Rest of Europe (10)
  • Asia-Pacific (Excluding Japan) (4)

For more information visit http://www.researchandmarkets.com/research/krx69g/prostate_cancer

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Prostate Cancer Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Prostate Cancer Drugs